Intima Bioscience Inc

We track 2 ClinicalTrials.gov studies led by Intima Bioscience Inc. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by Intima Bioscience Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by Intima Bioscience Inc

A Phase 1/2 Trial (CheckCell-2) in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC) Administering Tumor-Infiltrating Lymphocytes (TILs) in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System

NCT05566223 · WITHDRAWN · Phase 2

A Phase I/II Trial in Patients With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System

NCT04426669 · COMPLETED · Phase 2

Frequently Asked Questions

How many clinical trials does Intima Bioscience Inc sponsor?

Intima Bioscience Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Intima Bioscience Inc research?

Intima Bioscience Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Intima Bioscience Inc recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More